T1	Participants 82 141	middle-and-late stage tumor patients receiving chemotherapy
T2	Participants 326 353	middle-and-late stage tumor
T3	Participants 395 462	Recruited 60 patients were randomly assigned to the treatment group
T4	Participants 624 658	The therapeutic course was 8 weeks
#1	AnnotatorNotes T4	Time
T5	Participants 733 792	middle-and-late stage tumor patients receiving chemotherapy
